5//SEC Filing
Q Therapeutics, Inc. 5
Accession 0001209191-13-040380
CIK 0001366541operating
Filed
Aug 12, 8:00 PM ET
Accepted
Aug 13, 12:51 PM ET
Size
5.8 KB
Accession
0001209191-13-040380
Insider Transaction Report
Form 5
Q Therapeutics, Inc.[NONE]
GREBOW PETER E
Director
Transactions
- Award
Options to Purchase Common Stock
2012-01-01$1.00/sh+25,000$25,000→ 25,000 totalExercise: $1.00From: 2012-01-01Exp: 2022-01-01→ Common Stock (25,000 underlying)
Footnotes (2)
- [F1]Transaction was reported on the 2011 Form 5, but was reported incorrectly listing only the number of options that had vested in place of the number of options granted in entirety.
- [F2]Options vest at a rate of approximately 2,084 per month over the course of one year.
Documents
Issuer
Q Therapeutics, Inc.
CIK 0001366541
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001366541
Filing Metadata
- Form type
- 5
- Filed
- Aug 12, 8:00 PM ET
- Accepted
- Aug 13, 12:51 PM ET
- Size
- 5.8 KB